Belinda Guo

I completed my BSc Honours degree at the University of Canterbury in Christchurch, New Zealand, where I generated and characterised a mutant DHDPS (dihydrodipicolinate synthase) protein, which is a rate-limiting enzyme in lysine biosynthesis.

I completed my PhD degree at the University of Melbourne in 2014, where I investigated the role of exosomes (small membrane-bound vesicles released by cells) in prion disease. I used a range of molecular and cell biology techniques to examine how different cellular pathways regulate exosome formation, packaging of the prion protein, release from cells and subsequent intercellular transmission of prion infectivity.

I worked as a Research Assistant at the Bio21 Institute, University of Melbourne, where I undertook my PhD studies. I assisted with several projects, including continuations of my PhD project. In addition, I received training for and worked on next-generation sequencing (NGS) projects using the Ion Torrent Personal Genome Machine (PGM) platform.

I joined the Translational Cancer Pathology Laboratory in 2014, where I will apply my molecular and NGS skills to cancer research, with a focus on molecular genomic studies of melanoma, glioma and haematological malignancies.

Research Assistant, University of Melbourne, VIC, Australia

Molecular genomic studies of haematological malignancies including myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN).